Reports and Data has released a new report projecting that the global Blood Preparation Market will reach $63.57 billion by 2028 at a CAGR of 5.8%. The growth of the market is attributed to several factors including increasing prevalence of blood-related disorders, rising blood transfusion procedures, and growing applications of blood components and derivatives in various surgical procedures. Additionally, there has been an increasing awareness about blood donation, an increase in road accidents, and development of anti-thrombotic and anti-coagulant drugs, which have all contributed to the market's growth.
Blood preparation involves the preparation of vital blood components, including platelets, plasma, Red Blood Cells (RBCs), and White Blood Cells (WBCs). These components are separated from whole blood through centrifugation, and the blood preparation method is extensively used in procedures such as blood transfusions. Blood preparation is carried out in clinical laboratories and blood centers.
Request sample report @https://www.reportsanddata.com/download-free-sample/4019
The report highlights the key trends in the industry, including the growing use of blood derivatives, such as platelet-rich plasma, in procedures like blood transfusion, and the development of anti-thrombotic and anti-coagulant drugs. The report also identifies key market segments, such as whole blood, platelet concentrates, Packed Red Blood Cell (PRBC) concentrate, frozen plasma, and cryoprecipitate, and identifies that the North American market is expected to exhibit the highest revenue growth rate during the forecast period due to rising prevalence of blood cancer, expanding blood donation initiatives, and increasing research and development activities for blood components and derivatives.
The report also identifies key players in the market, including Johnson Johnson, GlaxoSmithKline PLC, Pfizer Inc., Celgene Corp, Baxter Healthcare Corp., AstraZeneca Co., Boehringer Ingelheim, Sanofi Aventis, Aralez Pharmaceuticals, Bristol-Myers Squibb Co., Leo Pharma Inc., Daiichi Sankyo, Shandong East Chemical Industry Co., Ionis Pharmaceuticals, and Bayer AG.
To know insights visit @https://www.reportsanddata.com/request-latest-insight/4019
The global blood preparation market has been segmented based on the product type, antithrombotic and anticoagulant type, application, and region. The whole blood segment is expected to account for the highest revenue share in the global blood preparation market over the forecast years, primarily due to the low costs and easy availability of whole blood, rising applications in blood transfusions, and increasing RD activities to develop blood products. In terms of application, the angina blood vessel complications segment leads the global market in terms of revenue, primarily due to rising prevalence of Cardiovascular Disorders (CVDs), increasing surgical procedures globally, rise in development of advanced anticoagulants, and growing awareness about cardiovascular health.
To request report customization @https://www.reportsanddata.com/request-customization-form/4019
https://www.sinp.msu.ru/ru/ext_link?url=https://www.reportsanddata.com
https://content.iospress.com/LOGOUT?dest=https://www.reportsanddata.com
https://spotlight.radiopublic.com/images/thumbnail?url=https://www.reportsanddata.com
